Evidence map›Paper›PMID 35768095›Full record

Observational studyBMJ open2022

Comparison of demographic, clinical and laboratory characteristics between first and second COVID-19 waves in a secondary care hospital in Qatar: a retrospective study.

Vamanjore A Naushad, Nishan K Purayil, Prem Chandra, Abazar Ahmad M Saeed, Pradeep Radhakrishnan, Irfan Varikkodan, Joe V Mathew, Jaseem Sirajudeen, Riyadh A Hammamy, Ahmad M Badi and 7 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Vamanjore A NaushadMedicine, Hamad Medical Corporation, Doha, Qatar nousha87@hotmail.com.ORCID 0000-0003-0751-1308
Nishan K PurayilMedicine, Hamad Medical Corporation, Doha, Qatar.
Prem ChandraMedical Research Center, Hamad Medical Corporation, Doha, Qatar.
Abazar Ahmad M SaeedMedicine, Hamad Medical Corporation, Doha, Qatar.
Pradeep RadhakrishnanMedicine, Hamad Medical Corporation, Doha, Qatar.
Irfan VarikkodanMedicine, Hamad Medical Corporation, Doha, Qatar.
Joe V MathewMedicine, Hamad Medical Corporation, Doha, Qatar.
Jaseem SirajudeenMedicine, Hamad Medical Corporation, Doha, Qatar.
Riyadh A HammamyMedicine, Hamad Medical Corporation, Doha, Qatar.
Ahmad M BadiMedicine, Hamad Medical Corporation, Doha, Qatar.
Aasir M SulimanMedicine, Hamad Medical Corporation, Doha, Qatar.
Mohamed N BadawiDepartment of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Saket AryaOphthalmology, Hamad Medical Corporation, Doha, Qatar.
Maryam AlMotawaClinical Medicine, Qatar University College of Medicine, Doha, Qatar.
Aisha Al-BakerClinical Medicine, Qatar University College of Medicine, Doha, Qatar.
Rania AlatomClinical Medicine, Qatar University College of Medicine, Doha, Qatar.
Anand KarthaMedicine, Hamad Medical Corporation, Doha, Qatar.
Hamad Medical Corporation · QAQatar University · QAWeill Cornell Medical College in Qatar · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the patient profile and outcomes in Qatar during the first and second waves of the COVID-19 pandemic.

settingA retrospective observational study was conducted comparing the demographic, clinical and laboratory characteristics of patients with COVID-19 infection admitted to a secondary care hospital, during the first and second waves of the pandemic.

participants1039 patients from the first wave and 991 from the second wave who had pneumonia on chest X-ray and had a confirmed SARS-CoV-2 infection by a real-time PCR test of a nasopharyngeal swab were included. Patients with a normal chest X-ray and those who had a negative PCR test despite a positive COVID-19 antigen test were excluded. OUTCOME: Length of stay, need for mechanical ventilation, final disposition and mortality were the key outcomes studied

resultsInfluenza like symptoms (18.5% in the first wave vs 36.1% in the second wave, p 0.001), cough (79.2% vs 87%, p<0.001) and dyspnoea (27.5% vs 38% p<0.001) were more common in the second wave. Second wave patients had significantly higher respiratory rate, lower peripheral oxygen saturation, needed more supplemental oxygen and had higher incidence of pulmonary embolism. More patients received hydroxychloroquine and antibiotics during the first wave and more received steroids, antivirals and interleukin-1 antagonist during the second wave. The second wave had a shorter length of stay (14.58±7.75 vs 12.61±6.16, p<0.001) and more patients were discharged home (22% vs 10%, p<0.001).

conclusionsPatients who presented during the second wave of COVID-19 pandemic appeared to be more ill clinically and based on their laboratory parameters. They required shorter hospitalisation and were more likely to be discharged home. This could represent greater expertise in handling such patients that was acquired during the first wave as well as use of more appropriate and combination therapies during the second wave.

Indexed as

COVID-19DemographyHospitalsHumansPandemicsQatarRetrospective StudiesSARS-CoV-2Secondary Health CareCOVID-19epidemiologyinfectious diseases

Identifiers

PMID35768095
PMCPMC9240448
OpenAlexW4283689067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.